Clinical Trials Browser

Phase 2 × Suspended × atezolizumab × Clear all

NCT06254911 2026-01-27

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Phase 2 Suspended

Oropharyngeal Neoplasms

NCT05620771 2025-10-20

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Phase 2 Suspended

Gastrointestinal

Carcinoma, Hepatocellular